Novartis
NVS
NVS
1,183 hedge funds and large institutions have $15.3B invested in Novartis in 2022 Q4 according to their latest regulatory filings, with 172 funds opening new positions, 297 increasing their positions, 496 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 1,088 → 1,183 (+95)
0.49% less ownership
Funds ownership: 7.62% → 7.12% (-0.49%)
40% less repeat investments, than reductions
Existing positions increased: 297 | Existing positions reduced: 496
Holders
1,183
Holding in Top 10
13
Calls
$798M
Puts
$341M
Top Buyers
| 1 | +$227M | |
| 2 | +$55.1M | |
| 3 | +$50.5M | |
| 4 |
Morgan Stanley
New York
|
+$34.3M |
| 5 |
Renaissance Technologies
New York
|
+$21.7M |
Top Sellers
| 1 | -$361M | |
| 2 | -$249M | |
| 3 | -$158M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$76.9M |
| 5 |
Goldman Sachs
New York
|
-$73.4M |